Extrapulmonary manifestations of COVID-19 patient presenting with abdominal pain and skin lesions as primary symptoms
DOI:
https://doi.org/10.18203/2349-2902.isj20211836Keywords:
COVID-19, Abdominal pain, Splenic infarction, Skin rashesAbstract
COVID-19 is basically a respiratory disease and pulmonary manifestations constitute main presentations of the disease however in some patients SARS-CoV-2 infection is not limited to the respiratory system and other organs can also be affected and may be the primary manifestations of the disease.Renal dysfunction, gastrointestinal complications, liver dysfunction, cardiac manifestations, neurological abnormalities, haematological and thrombotic manifestations are among the reported extrapulmonary features. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury. In addition, endothelial damage and thrombo-inflammation, dysregulation of immune responses, and maladaptation of ACE2-related pathways might all contribute to these extrapulmonary manifestations of COVID-19. Considering the broad spectrum of clinical manifestations and the increasing worldwide burden of the disease, there is an urgent need to evaluate patients presenting with abdominal symptoms and skin lesions even without respiratory complaints to increase the diagnostic accuracy to detect COVID-19 and its complications in early stage. Our case report documents a patient who presented with abdominal symptoms and skin lesions whose RT-PCR was positive for COVID-19. It remains to be seen whether these patients will eventually develop respiratory symptoms. Further studies are needed to elaborate and confirm the causative relationship between SARS-CoV-2 and the reported extrapulmonary manifestations of COVID-19.
References
Voutsinas N, Toussie D, Jacobi A, Bernheim A, Chung M. Incidental CT findings in the lungs in COVID-19 patients presenting with abdominal pain. Clin Imaging. 2020;67:1-4.
Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78.
Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-9.
Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China J Infect. 2020;80(4):388-93.
Del Rio C, Malani PN. COVID-19-New Insights on a Rapidly Changing Epidemic. J Am Med Assoc. 2020;323(14):1339-40.
Miri SM, Roozbeh F, Omranirad A, Alavian S M. Panic of Buying Toilet Papers: A Historical Memory or a Horrible Truth? Systematic Review of Gastrointestinal Manifestations of COVID-19, Hepat Mon. 2020;20(3):102729.
Santos M, Lima FC, Pimentel AC, Costa JC, Holanda JL. Multisystemic Infarctions in COVID-19: Focus on the Spleen. Eur J Case Rep Intern Med. 2020;7(7):001747.
Up To Date. Coronavirus disease 2019 (COVID-19): Cutaneous manifestations and issues related to dermatologic care. Available at: https://www.uptodate.com/contents/covid-19-cutaneous-manifestations-and-issues-related-to-dermatologic-care. Accessed on 29 August 2020.
Usher AD. WHO launches crowdfund for COVID-19 response. Lancet. 2020;395(10229):1024.
